ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P49917


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name DNL4_HUMAN
Primary accession number P49917
Secondary accession numbers Q8IY66 Q8TEU5
Integrated into Swiss-Prot on October 1, 1996
Sequence was last modified on February 7, 2006 (Sequence version 2)
Annotations were last modified on    July 22, 2008 (Entry version 97)
Name and origin of the protein
Protein name DNA ligase 4
Synonyms EC 6.5.1.1
DNA ligase IV
Polydeoxyribonucleotide synthase [ATP] 4
Gene name
Name: LIG4
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
TISSUE=Prostate;
PubMed=7760816 [NCBI, ExPASy, EBI, Israel, Japan]
Wei Y.-F., Robins P., Carter K., Caldecott K., Pappin D.J.C., Yu G.-L., Wang R.-P., Shell B.K., Nash R.A., Schar P., Barnes D.E., Haseltine W.A., Lindahl T.;
"Molecular cloning and expression of human cDNAs encoding a novel DNA ligase IV and DNA ligase III, an enzyme active in DNA repair and recombination.";
Mol. Cell. Biol. 15:3206-3216(1995).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-231 AND THR-857.
Rieder M.J., Braun A.C., Montoya M.A., Chung M.-W., Nguyen C.P., Nguyen D.A., Livingston R.J., Poel C.L., Robertson P.D., Schackwitz W.S., Sherwood J.K., Witrak L.A., Nickerson D.A.;
"NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu).";
Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature02379; PubMed=15057823 [NCBI, ExPASy, EBI, Israel, Japan]
Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L., Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P., Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L., Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S., Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
"The DNA sequence and analysis of human chromosome 13.";
Nature 428:522-528(2004).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Brain;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[5]
CHARACTERIZATION.
DOI=10.1074/jbc.271.39.24257; PubMed=8798671 [NCBI, ExPASy, EBI, Israel, Japan]
Robins P., Lindahl T.;
"DNA ligase IV from HeLa cell nuclei.";
J. Biol. Chem. 271:24257-24261(1996).
[6]
FUNCTION, AND INTERACTION WITH XRCC4.
DOI=10.1016/S1097-2765(00)80147-1; PubMed=9809069 [NCBI, ExPASy, EBI, Israel, Japan]
Grawunder U., Zimmer D., Fugmann S., Schwarz K., Lieber M.R.;
"DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes.";
Mol. Cell 2:477-484(1998).
[7]
INTERACTION WITH XRCC4.
DOI=10.1016/S0960-9822(06)00258-2; PubMed=9259561 [NCBI, ExPASy, EBI, Israel, Japan]
Critchlow S.E., Bowater R.P., Jackson S.P.;
"Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV.";
Curr. Biol. 7:588-598(1997).
[8]
FUNCTION, AND INTERACTION WITH XRCC4; G22P1; G22P2 AND PRKDC.
DOI=10.1074/jbc.M000491200; PubMed=10854421 [NCBI, ExPASy, EBI, Israel, Japan]
Chen L., Trujillo K., Sung P., Tomkinson A.E.;
"Interactions of the DNA ligase IV-XRCC4 complex with DNA ends and the DNA-dependent protein kinase.";
J. Biol. Chem. 275:26196-26205(2000).
[9]
IDENTIFICATION IN A COMPLEX WITH G22P1; G22P2 AND PRKDC.
DOI=10.1016/S0022-2836(02)01328-1; PubMed=12547193 [NCBI, ExPASy, EBI, Israel, Japan]
Calsou P., Delteil C., Frit P., Drouet J., Salles B.;
"Coordinated assembly of Ku and p460 subunits of the DNA-dependent protein kinase on DNA ends is necessary for XRCC4-ligase IV recruitment.";
J. Mol. Biol. 326:93-103(2003).
[10]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-347, AND MASS SPECTROMETRY.
DOI=10.2116/analsci.24.161; PubMed=18187866 [NCBI, ExPASy, EBI, Israel, Japan]
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Anal. Sci. 24:161-166(2008).
[11]
X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 748-784 IN COMPLEX WITH XRCC4.
DOI=10.1038/nsb725; PubMed=11702069 [NCBI, ExPASy, EBI, Israel, Japan]
Sibanda B.L., Critchlow S.E., Begun J., Pei X.Y., Jackson S.P., Blundell T.L., Pellegrini L.;
"Crystal structure of an Xrcc4-DNA ligase IV complex.";
Nat. Struct. Biol. 8:1015-1019(2001).
[12]
STRUCTURE BY NMR OF 654-759.
RIKEN structural genomics initiative (RSGI);
"Solution structure of the first BRCT domain of human DNA ligase IV.";
Submitted (DEC-2006) to the PDB data bank.
[13]
VARIANT LEUKEMIA HIS-278.
DOI=10.1016/S0960-9822(99)80311-X; PubMed=10395545 [NCBI, ExPASy, EBI, Israel, Japan]
Riballo E., Critchlow S.E., Teo S.-H., Doherty A.J., Priestley A., Broughton B.C., Kysela B., Beamish H., Plowman N., Arlett C.F., Lehmann A.R., Jackson S.P., Jeggo P.A.;
"Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient.";
Curr. Biol. 9:699-702(1999).
[14]
CHARACTERIZATION OF VARIANT HIS-278.
DOI=10.1074/jbc.M103866200; PubMed=11349135 [NCBI, ExPASy, EBI, Israel, Japan]
Riballo E., Doherty A.J., Dai Y., Stiff T., Oettinger M.A., Jeggo P.A., Kysela B.;
"Cellular and biochemical impact of a mutation in DNA ligase IV conferring clinical radiosensitivity.";
J. Biol. Chem. 276:31124-31132(2001).
[15]
VARIANTS LIG4 SYNDROME HIS-278 AND GLU-469.
DOI=10.1016/S1097-2765(01)00408-7; PubMed=11779494 [NCBI, ExPASy, EBI, Israel, Japan]
O'Driscoll M., Cerosaletti K.M., Girard P.-M., Dai Y., Stumm M., Kysela B., Hirsch B., Gennery A., Palmer S.E., Seidel J., Gatti R.A., Varon R., Oettinger M.A., Neitzel H., Jeggo P.A., Concannon P.;
"DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency.";
Mol. Cell 8:1175-1185(2001).
[16]
VARIANTS VAL-3 AND ILE-9, AND ASSOCIATION WITH RESISTANCE TO MULTIPLE MYELOMA.
DOI=10.1136/jmg.39.12.900; PubMed=12471202 [NCBI, ExPASy, EBI, Israel, Japan]
Roddam P.L., Rollinson S., O'Driscoll M., Jeggo P.A., Jack A., Morgan G.J.;
"Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination.";
J. Med. Genet. 39:900-905(2002).
[17]
VARIANT RS-SCID GLN-433 DEL.
DOI=10.1172/JCI26121; PubMed=16357942 [NCBI, ExPASy, EBI, Israel, Japan]
van der Burg M., van Veelen L.R., Verkaik N.S., Wiegant W.W., Hartwig N.G., Barendregt B.H., Brugmans L., Raams A., Jaspers N.G.J., Zdzienicka M.Z., van Dongen J.J.M., van Gent D.C.;
"A new type of radiosensitive T-B-NK(+) severe combined immunodeficiency caused by a LIG4 mutation.";
J. Clin. Invest. 116:137-145(2006).
Comments
  • FUNCTION: Efficiently joins single-strand breaks in a double-stranded polydeoxynucleotide in an ATP-dependent reaction. Involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination. The LIG4-XRCC4 complex is responsible for the NHEJ ligation step, and XRCC4 enhances the joining activity of LIG4. Binding of the LIG4-XRCC4 complex to DNA ends is dependent on the assembly of the DNA-dependent protein kinase complex DNA-PK to these DNA ends.
  • CATALYTIC ACTIVITY: ATP + (deoxyribonucleotide)(n) + (deoxyribonucleotide)(m) = AMP + diphosphate + (deoxyribonucleotide)(n+m).
  • SUBUNIT: Binds to XRCC4. The LIG4-XRCC4 complex has probably a 1:2 stoichiometry. The LIG4-XRCC4 heteromer associates in a DNA-dependent manner with the DNA-dependent protein kinase complex DNA-PK, formed by the Ku p70/p86 dimer (G22P1/G22P2) and PRKDC.
  • INTERACTION:
    Q9H9Q4:NHEJ1; NbExp=4; IntAct=EBI-847896, EBI-847807;
    Q96T60:PNKP; NbExp=1; IntAct=EBI-847896, EBI-1045072;
  • SUBCELLULAR LOCATION: Nucleus.
  • TISSUE SPECIFICITY: Testis, thymus, prostate and heart.
  • DISEASE: Defects in LIG4 are the cause of LIG4 syndrome [MIM:606593]. This disease is characterized by immunodeficiency and developmental and growth delay. Patients display unusual facial features, microcephaly, growth and/or developmental delay, pancytopenia, and various skin abnormalities.
  • DISEASE: Defects in LIG4 are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive with sensitivity to ionizing radiation (RSSCID) [MIM:602450]. SCID refers to a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients with SCID present in infancy with recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development. Individuals affected by RS-SCID show defects in the DNA repair machinery necessary for coding joint formation and the completion of V(D)J recombination. A subset of cells from such patients show increased radiosensitivity.
  • SIMILARITY: Belongs to the ATP-dependent DNA ligase family.
  • SIMILARITY: Contains 2 BRCT domains.
  • WEB RESOURCE: Name=LIG4base; Note=LIG4 mutation db; URL="http://bioinf.uta.fi/LIG4base/";.
  • WEB RESOURCE: Name=Wikipedia; Note=DNA ligase entry; URL="http://en.wikipedia.org/wiki/DNA_ligase";.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
X83441; CAA58467.1; ALT_INIT; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF479264; AAL77435.1; ALT_INIT; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AL157762; CAH70629.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC037491; AAH37491.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR I37079; I37079.
RefSeq NP_001091738.1; -.
NP_002303.2; -.
NP_996820.1; -.
UniGene Hs.166091
3D structure databases
PDB
1IK9; X-ray; 2.30 A; C=748-784.[ExPASy / RCSB / EBI]
2E2W; NMR; -; A=654-759.[ExPASy / RCSB / EBI]
Detailed list of linked structures.
PDBsum 1IK9; -.
2E2W; -.
ModBase P49917.
Protein-protein interaction databases
IntAct P49917; -.
PTM databases
PhosphoSite P49917; -.
Enzyme and pathway databases
Reactome REACT_216; DNA Repair.
REACT_6185; HIV Infection.
Polymorphism databases
NIEHS-SNPs LIG4.
Organism-specific databases
H-InvDB HIX0026564; -.
HGNC HGNC:6601; LIG4.
GenAtlas LIG4.
HPA HPA001334; -.
MIM 601837; gene. [NCBI / EBI]
602450; phenotype. [NCBI / EBI]
606593; phenotype. [NCBI / EBI]
Orphanet 647; Nijmegen breakage syndrome.
PharmGKB PA30375; -.
GeneCards P49917.
Gene expression databases
ArrayExpress P49917; -.
CleanEx HS_LIG4; -.
GermOnline ENSG00000174405; Homo sapiens.
Ontologies
GO
GO:0000793; Cellular component: condensed chromosome (inferred from direct assay from UniProtKB).
GO:0032807; Cellular component: DNA ligase IV complex (inferred from mutant phenotype from UniProtKB).
GO:0005958; Cellular component: DNA-dependent protein kinase complex (inferred from sequence or structural similarity from UniProtKB).
GO:0005524; Molecular function: ATP binding (inferred by curator from UniProtKB).
GO:0003677; Molecular function: DNA binding (inferred from direct assay from UniProtKB).
GO:0003910; Molecular function: DNA ligase (ATP) activity (inferred from direct assay from UniProtKB).
GO:0008022; Molecular function: protein C-terminus binding (inferred from physical interaction from UniProtKB).
GO:0007417; Biological process: central nervous system development (inferred from sequence or structural similarity from UniProtKB).
GO:0051276; Biological process: chromosome organization (inferred from sequence or structural similarity from UniProtKB).
GO:0051102; Biological process: DNA ligation during DNA recombination (inferred from sequence or structural similarity from UniProtKB).
GO:0051103; Biological process: DNA ligation during DNA repair (inferred from direct assay from UniProtKB).
GO:0006303; Biological process: double-strand break repair via nonhomologous end joining (inferred from direct assay from UniProtKB).
GO:0001701; Biological process: in utero embryonic development (inferred from sequence or structural similarity from UniProtKB).
GO:0019059; Biological process: initiation of viral infection (inferred from experiment from Reactome).
GO:0045190; Biological process: isotype switching (inferred from sequence or structural similarity from UniProtKB).
GO:0043524; Biological process: negative regulation of neuron apoptosis (inferred from sequence or structural similarity from UniProtKB).
GO:0006297; Biological process: nucleotide-excision repair, DNA gap filling (inferred from direct assay from UniProtKB).
GO:0048146; Biological process: positive regulation of fibroblast proliferation (inferred from sequence or structural similarity from UniProtKB).
GO:0050769; Biological process: positive regulation of neurogenesis (inferred from sequence or structural similarity from UniProtKB).
GO:0002328; Biological process: pro-B cell differentiation (inferred from sequence or structural similarity from UniProtKB).
GO:0019047; Biological process: provirus integration (inferred from experiment from Reactome).
GO:0010332; Biological process: response to gamma radiation (inferred from sequence or structural similarity from UniProtKB).
GO:0010165; Biological process: response to X-ray (inferred from mutant phenotype from UniProtKB).
GO:0000012; Biological process: single strand break repair (inferred from direct assay from UniProtKB).
GO:0035019; Biological process: somatic stem cell maintenance (inferred from sequence or structural similarity from UniProtKB).
GO:0033077; Biological process: T cell differentiation in the thymus (inferred from sequence or structural similarity from UniProtKB).
GO:0033153; Biological process: T cell receptor V(D)J recombination (inferred from sequence or structural similarity from UniProtKB).
QuickGo view.
Family and domain databases
InterPro IPR001357; BRCT.
IPR000977; DNA_ligase.
IPR012309; DNA_ligase_A_C.
IPR012310; DNA_ligase_A_M.
IPR012308; DNA_ligase_A_N.
IPR016059; DNA_ligase_CS.
IPR012340; NA-bd_OB-fold.
Graphical view of domain structure.
Gene3D G3DSA:2.40.50.140; OB_NA_bd_sub; 1.
Pfam PF00533; BRCT; 2.
PF04679; DNA_ligase_A_C; 1.
PF01068; DNA_ligase_A_M; 1.
PF04675; DNA_ligase_A_N; 1.
Pfam graphical view of domain structure.
SMART SM00292; BRCT; 2.
SMART graphical view of domain structure.
TIGRFAMs TIGR00574; dnl1; 1.
PROSITE PS50172; BRCT; 2.
PS00697; DNA_LIGASE_A1; 1.
PS00333; DNA_LIGASE_A2; 1.
PS50160; DNA_LIGASE_A3; 1.
PROSITE graphical view of domain structure (profiles).
BLOCKS P49917.
Genome annotation databases
Ensembl ENSG00000174405; Homo sapiens. [Contig view]
GeneID 3981; -.
KEGG hsa:3981; -.
Phylogenomic databases
HOGENOM P49917; -.
HOVERGEN P49917; -.
Other
LinkHub P49917; -.
SOURCE LIG4; Homo sapiens.
ProtoNet P49917.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; ATP-binding; Cell cycle; Cell division; Direct protein sequencing; Disease mutation; DNA damage; DNA recombination; DNA repair; DNA replication; Ligase; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism; Repeat; SCID.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom   To Length Description FTId
CHAIN   1   911  911     DNA ligase 4. PRO_0000059576
DOMAIN   654   743  90     BRCT 1. 
DOMAIN   808   911  104     BRCT 2. 
ACT_SITE   273   273        N6-AMP-lysine intermediate (By similarity). 
MOD_RES   347   347        Phosphothreonine. 
VARIANT   3     3  1     A -> V (associated with resistance to multiple myeloma; dbSNP:rs1805389 [NCBI]). VAR_029352 
VARIANT   9     9  1     T -> I (associated with resistance to multiple myeloma; dbSNP:rs1805388 [NCBI]). VAR_033884 
VARIANT   62    62  1     D -> H (in dbSNP:rs3093763 [NCBI]). VAR_029353 
VARIANT   231   231  1     P -> S (in dbSNP:rs3093765 [NCBI]). VAR_018808 
VARIANT   278   278  1     R -> H (in LIG4 syndrome and leukemia; impairs activity). VAR_012774 
VARIANT   433   433  1     Missing (in RS-SCID). VAR_044123
VARIANT   461   461  1     E -> G (in dbSNP:rs2232640 [NCBI]). VAR_044124 
VARIANT   469   469  1     G -> E (in LIG4 syndrome). VAR_012775 
VARIANT   539   539  1     L -> F (in dbSNP:rs3742212 [NCBI]). VAR_016771 
VARIANT   658   658  1     I -> V (in dbSNP:rs2232641 [NCBI]). VAR_016772 
VARIANT   857   857  1     A -> T (in dbSNP:rs2232642 [NCBI]). VAR_016773 
CONFLICT   246   246        F -> S (in Ref. 1; CAA58467). 
TURN   658   661  4      
STRAND   662   668  7      
STRAND   671   673  3      
HELIX   675   684  10      
STRAND   687   692  6      
STRAND   700   704  5      
HELIX   707   715  9      
HELIX   723   732  10      
TURN   740   742  3      
STRAND   743   745  3      
STRAND   764   767  4      
HELIX   771   779  9      
Sequence information
Length: 911 AA [This is the length of the unprocessed precursor] Molecular weight: 103971 Da [This is the MW of the unprocessed precursor] CRC64: 2122813E1EFA63B9 [This is a checksum on the sequence]
        10         20         30         40         50         60 
MAASQTSQTV ASHVPFADLC STLERIQKSK GRAEKIRHFR EFLDSWRKFH DALHKNHKDV 

        70         80         90        100        110        120 
TDSFYPAMRL ILPQLERERM AYGIKETMLA KLYIELLNLP RDGKDALKLL NYRTPTGTHG 

       130        140        150        160        170        180 
DAGDFAMIAY FVLKPRCLQK GSLTIQQVND LLDSIASNNS AKRKDLIKKS LLQLITQSSA 

       190        200        210        220        230        240 
LEQKWLIRMI IKDLKLGVSQ QTIFSVFHND AAELHNVTTD LEKVCRQLHD PSVGLSDISI 

       250        260        270        280        290        300 
TLFSAFKPML AAIADIEHIE KDMKHQSFYI ETKLDGERMQ MHKDGDVYKY FSRNGYNYTD 

       310        320        330        340        350        360 
QFGASPTEGS LTPFIHNAFK ADIQICILDG EMMAYNPNTQ TFMQKGTKFD IKRMVEDSDL 

       370        380        390        400        410        420 
QTCYCVFDVL MVNNKKLGHE TLRKRYEILS SIFTPIPGRI EIVQKTQAHT KNEVIDALNE 

       430        440        450        460        470        480 
AIDKREEGIM VKQPLSIYKP DKRGEGWLKI KPEYVSGLMD ELDILIVGGY WGKGSRGGMM 

       490        500        510        520        530        540 
SHFLCAVAEK PPPGEKPSVF HTLSRVGSGC TMKELYDLGL KLAKYWKPFH RKAPPSSILC 

       550        560        570        580        590        600 
GTEKPEVYIE PCNSVIVQIK AAEIVPSDMY KTGCTLRFPR IEKIRDDKEW HECMTLDDLE 

       610        620        630        640        650        660 
QLRGKASGKL ASKHLYIGGD DEPQEKKRKA APKMKKVIGI IEHLKAPNLT NVNKISNIFE 

       670        680        690        700        710        720 
DVEFCVMSGT DSQPKPDLEN RIAEFGGYIV QNPGPDTYCV IAGSENIRVK NIILSNKHDV 

       730        740        750        760        770        780 
VKPAWLLECF KTKSFVPWQP RFMIHMCPST KEHFAREYDC YGDSYFIDTD LNQLKEVFSG 

       790        800        810        820        830        840 
IKNSNEQTPE EMASLIADLE YRYSWDCSPL SMFRRHTVYL DSYAVINDLS TKNEGTRLAI 

       850        860        870        880        890        900 
KALELRFHGA KVVSCLAEGV SHVIIGEDHS RVADFKAFRR TFKRKFKILK ESWVTDSIDK 

       910 
CELQEENQYL I 

P49917 in FASTA format

View entry in original UniProtKB/Swiss-Prot format
View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ch flag SIB Switzerland Mirror sites: Australia  Brazil  Canada  China  Korea
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!